The vanilloid receptor TRPV1 has been identified as a molecular target for the treatment of
pain associated with inflammatory diseases and cancer. Hence, TRPV1 antagonists have …

Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an autosomal
dominant heart muscle disorder that causes arrhythmia, heart failure, and sudden death. …

The vanilloid receptor 1 (VR1 or TRPV1) is a membrane-bound, nonselective cation channel
expressed by peripheral sensory neurons. TRPV1 antagonists produce antihyperalgesic …

Objectives : We sought to ascertain the prevalence and mode of expression of familial disease
in a consecutive series of patients with arrhythmogenic right ventricular cardiomyopathy/…

The vanilloid receptor TRPV1 (transient receptor potential vanilloid 1) is a cation channel that
serves as a polymodal detector of pain-producing stimuli such as capsaicin, protons (pH <…

Background— Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a familial heart
muscle disease characterized by structural, electrical, and pathological abnormalities of the …

In most cancers, transformation begins in a single cell in an epithelial cell sheet 1 , 2 , 3 .
However, it is not known what happens at the interface between non-transformed (normal) and …

The use of tools has become a benchmark for cognitive sophistication. Originally regarded as
a defining feature of our species, tool-use behaviours have subsequently been revealed in …

The development of antagonists of the transient receptor potential vanilloid-1 (TRPV1) channel
as pain therapeutics has revealed that these compounds cause hyperthermia in humans. …

Octopuses of the family Octopodidae adopt two major life-history strategies. The rst is the
production of relatively few, large eggs resulting in well-developed hatchlings that resemble the …